Navigation Links
RCRC Independent Review Board Announces DHHS Research Oversight
Date:9/25/2009

RCRC IRB announces new service -- oversight of research supported by or conducted by the US Department of Health and Human Services.

Austin, TX (PRWEB) September 25, 2009 -- RCRC Independent Review Board, providing ethical review services for greater than 20 years, announced today that it will provide oversight of research supported or conducted by a federal department or agency within the Department of Health and Human Services (HHS).

"We are very pleased to announce these new services of RCRC IRB for the clinical research community. Expanding and continually enhancing the protection of research subjects is a core value of our organization, and these efforts are an important component of our overall program," stated Priscilla Short, RCRC Executive Director.

The Office for Human Research Protections (OHRP) maintains regulatory oversight of research supported or conducted by the US Department of Health and Human Services. This research is governed by HHS regulations -- Title 45, Part 46, Code of Federal Regulations (45 CFR part 46). RCRC has modified its policies to ensure compliance with these regulations.

RCRC is also subject to regulation by the Food and Drug Administration (FDA) for its oversight of FDA regulated research involving drug, devices, and biologics.

RCRC is registered with the US Department of Health and Human Services IRB Registration System.

RCRC is a fully accredited, leading provider of professional IRB services, providing IRB review for clients nationwide. RCRC provides ethical review for all phases of research in a variety of therapeutic areas and has extensive experience in single-site trials, multi-site trials and mega trials. RCRC offers two weekly review board meetings and a 24-48 hour turnaround time. For further information visit www.rcrc-irb.com.

For Additional Information Contact

Priscilla Short
Executive Director
RCRC Independent Review Board
+1 512.380.1244 Ext. 200

###

Read the full story at http://www.prweb.com/releases/2009/09/prweb2935214.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. URAC Open Public Comment Period for New Independent Review Organization Standards
2. GSK Limits Medical Education Funding to Independent Programs With Highest Impact on Patient Care
3. Gentiva(R) Health Services Announces Appointment of Three Independent Directors
4. 2 Independent Studies Released on the Effectiveness of Prostate Cancer Treatment
5. Independent Analysis Shows Granite Countertops Pose No Health Risk
6. BioNeutrals Ygiene(TM) Achieves Worlds Fastest Kill Time With a 100% Total Spore Eradication Verified In Independent Sporicidal/Sterilant Test
7. China Medical Technologies Announces Change of Independent Auditors
8. Cardinal Health Welcomes Record Number of Attendees at its Annual Independent Pharmacy Trade Show
9. China Medical Technologies Announces the Substantial Completion of an Independent Internal Investigation and Expected Timing of Reporting of Unaudited Financial Results for the Quarter and Fiscal Year ended March 31, 2009 and the Quarter ended June 30, 20
10. Leading Independent Analyst Firm States Silver Creek Systems Holds A Virtual Monopoly In Delivering Advanced Product Data Quality Capabilities
11. Medifast Independent Director Lt. Gen. Dennis McCarthy Confirmed as Assistant Secretary of Defense for Reserve Affairs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2016)... ... May 23, 2016 , ... While new U.S. opioid ... physicians are not legally required to follow them. In the absence of federal ... Novus Medical Detox Center , a leading Florida-based drug treatment facility, strongly ...
(Date:5/23/2016)... ... ... the upcoming airing of Innovations with Ed Begley, Jr., ... 4:00pET via Fox Business. , The show will explore ... safely and rapidly develop cures for mosquito-borne, emerging infectious ...
(Date:5/23/2016)... , ... May 23, 2016 ... ... Size for Verification and Validation:, Tools to Safely Speed Your Device to ... http://www.fdanews.com/bestdevicesamplesizevv                  , Today's FDA inspectors focus like lasers on device ...
(Date:5/23/2016)... (PRWEB) , ... May 23, 2016 , ... ... the action analytics leader as Chief Medical Officer. Dr. O’Connor’s deep expertise in ... product development and client services teams who deliver best-in-class solutions and transformative technologies ...
(Date:5/23/2016)... Valley, California (PRWEB) , ... May 23, 2016 ... ... clinical communications and solutions for healthcare providers announced today that AGNITY MobileCare™ Platform ... and health collaboration applications as a part of its M-Health Solution. Tech Mahindra ...
Breaking Medicine News(10 mins):
(Date:5/19/2016)... Israel , May 19, 2016 ... the "Company"), an emerging global ophthalmic company focused on ... candidates which address ophthalmic conditions, announced today that it ... Italy ) for the manufacturing, distribution, marketing ... for the treatment of dry eye syndrome (DES) and ...
(Date:5/19/2016)... May 19, 2016 A ... World Biopsy Devices Market Opportunities and Forecasts, 2014 ... market generated $1,621 million in 2015. The MRI-guided ... and is expected to maintain this trend over ... http://photos.prnewswire.com/prnh/20140911/647229 ) , To know ...
(Date:5/19/2016)... BioLineRx Ltd. (NASDAQ/TASE: BLRX) announced ... of multiple cancer and hematological indications, will be presented ... titled " Clinical response in relapsed/refractory AML patients correlates ... a potent CXCR4 antagonist; results of a Phase 2a ... the European Hematology Association 21st Congress, to be held ...
Breaking Medicine Technology: